148 related articles for article (PubMed ID: 1802621)
1. Recombinant human erythropoietin. Experimental and clinical applications.
Nielsen OJ
Dan Med Bull; 1991 Oct; 38(5):355-70. PubMed ID: 1802621
[No Abstract] [Full Text] [Related]
2. Recombinant human erythropoietin: experimental and clinical applications.
Nielsen OJ
Scand J Clin Lab Invest; 1991 Feb; 51(1):1-10. PubMed ID: 2020826
[No Abstract] [Full Text] [Related]
3. Erythropoietin: biological aspects and clinical usefulness.
Liberato NL; Costa A; Barosi G
Haematologica; 1990; 75(4):346-62. PubMed ID: 2276680
[TBL] [Abstract][Full Text] [Related]
4. [Erythropoietin: its biological properties and clinical use].
Ermolenko VM; Nikolaev AIu
Ter Arkh; 1990; 62(11):141-5. PubMed ID: 2094979
[No Abstract] [Full Text] [Related]
5. [Recombinant human erythropoietin].
Montloin A
Rev Infirm; 1990 Dec; 40(19):33-4. PubMed ID: 2091207
[No Abstract] [Full Text] [Related]
6. A randomized, placebo-controlled clinical trial of recombinant human erythropoietin in the anemia of prematurity.
Mentzer WC; Shannon KM; Abels RI; Freeman P; Newton N; Thompson D; Phibbs RH
Contrib Nephrol; 1991; 88():306-12; discussion 313. PubMed ID: 2040193
[No Abstract] [Full Text] [Related]
7. [Two new drugs. Recombinant "human" erythropoietin (EPO: Erypo, Recormon)].
Verwiebe R
Internist (Berl); 1992 Apr; 33(4):279-81. PubMed ID: 1612854
[No Abstract] [Full Text] [Related]
8. [Human recombinant erythropoietin: from clinical aspects to the physiopathology of anemia of renal insufficiency].
Wauters JP
Rev Med Suisse Romande; 1990 Nov; 110(11):951-4. PubMed ID: 2267466
[No Abstract] [Full Text] [Related]
9. [Recombinant human erythropoietin].
Frenken LA; Koene RA
Ned Tijdschr Geneeskd; 1988 Mar; 132(10):432-4. PubMed ID: 3347279
[No Abstract] [Full Text] [Related]
10. Biological characterization of recombinant human erythropoietin.
Krumwieh D; Arnold I; Seiler FR
Behring Inst Mitt; 1988 Aug; (83):193-201. PubMed ID: 3240225
[TBL] [Abstract][Full Text] [Related]
11. Clinical application of erythropoietin.
Urabe A; Kitamura T; Takaku F
Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1355-9. PubMed ID: 3073611
[No Abstract] [Full Text] [Related]
12. [New data on the mechanism of inhibition of erythropoiesis at the beginning of nitrogen deficiency. Probalitity of hepatic, splenic and renal retention of erythropoietin in rats deficient in proteins].
Aschkenasy A
Arch Sci Physiol (Paris); 1968; 22(3):357-75. PubMed ID: 5721885
[No Abstract] [Full Text] [Related]
13. [Recombinant human erythropoietin and chronic kidney failure: current situation and therapeutic implications].
Romero González R; Torquet Escuder P
Med Clin (Barc); 1990 Nov; 95(17):656-9. PubMed ID: 2089205
[No Abstract] [Full Text] [Related]
14. Erythropoietin: from molecular biology to clinical use.
Lacombe C
Eur Cytokine Netw; 1997 Sep; 8(3):308-10. PubMed ID: 9346370
[No Abstract] [Full Text] [Related]
15. Erythropoietin therapy for anemia of prematurity.
Gallagher PG; Ehrenkranz RA
Clin Perinatol; 1993 Mar; 20(1):169-91. PubMed ID: 8458164
[TBL] [Abstract][Full Text] [Related]
16. The anemia of chronic renal failure: pathophysiology and effects of recombinant erythropoietin.
Eschbach JW; Haley NR; Adamson JW
Contrib Nephrol; 1990; 78():24-36; discussion 37. PubMed ID: 2225841
[No Abstract] [Full Text] [Related]
17. Guidelines for the use of recombinant human erythropoietin.
Barosi G; Cazzola M; De Vincentiis A; Grossi A; Tura S
Haematologica; 1994; 79(6):526-33. PubMed ID: 7896210
[No Abstract] [Full Text] [Related]
18. Erythropoietin for anemia.
Med Lett Drugs Ther; 1989 Sep; 31(801):85-6. PubMed ID: 2671624
[No Abstract] [Full Text] [Related]
19. Analysis of initial resistance of erythropoiesis to treatment with recombinant human erythropoietin. Results of a multicenter trial in patients with end-stage renal disease.
Kühn K; Nonnast-Daniel B; Grützmacher P; Grüner J; Pfåffl W; Baldamus CA; Scigalla P
Contrib Nephrol; 1988; 66():94-103. PubMed ID: 3292152
[No Abstract] [Full Text] [Related]
20. Dose-related effects of recombinant human erythropoietin on erythropoiesis. Results of a multicenter trial in patients with end-stage renal disease.
Bommer J; Kugel M; Schoeppe W; Brunkhorst R; Samtleben W; Bramsiepe P; Scigalla P
Contrib Nephrol; 1988; 66():85-93. PubMed ID: 3292151
[No Abstract] [Full Text] [Related]
[Next] [New Search]
